Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
metastatic NSCLC with HER2 exon 20 insertion mutations.
.
Show all posts
Showing posts with label
metastatic NSCLC with HER2 exon 20 insertion mutations.
.
Show all posts
Thursday, January 6, 2022
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib for metastatic NSCLC with HER2 exon 20 insertion mutations.
›
Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, announced tha...
›
Home
View web version
